FMR CORP 13D and 13G filings for Candel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 10:18 am Purchase |
2025-01-31 | 13G | Candel Therapeutics, Inc. CADL |
FMR CORP | 6,318,721 15.000% |
2,395,122 (+61.04%) |
Filing |
| 2025-02-07 10:03 am Purchase |
2024-12-31 | 13G | Candel Therapeutics, Inc. CADL |
FMR CORP | 3,923,599 9.300% |
3,186,003 (+431.94%) |
Filing |
| 2023-02-09 09:59 am Sale |
2023-02-09 | 13G | Candel Therapeutics, Inc. CADL |
FMR CORP | 737,596 2.552% |
-1,525,246 (-67.40%) |
Filing |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Candel Therapeutics, Inc. CADL |
FMR CORP | 2,262,842 7.887% |
2,262,842 (New Position) |
Filing |